Since HACE1 is the target of epigenetic inactivation in Wilms’ tumor and has been proposed as a tumor suppressor gene in multiple human cancers, it is tempting to speculate that HACE1 might be involved in the pathogenesis of NKTCL (Huang et al., 2010). This evidence concerns the gene HACE1 and extranodal nasal NK/T cell lymphoma.